The aim of this study was to measure the effect of low- and high-dose lipid-lowering treatment with rosuvastatin on the coronary physiology parameters.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
87
Rosuvastatin 5mg/day for one year
Rosuvastatin 40mg/day for one year
Department of Cardiology, Odense University Hospital
Odense, Fuenen, Denmark
The primary endpoint was the change from baseline in Index of microcirculatory resistance(IMR).
Time frame: One year
The secondary endpoints were the changes from baseline in Fractional Flow Reserve (FFR) and lipid values.
Time frame: One year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.